Expression and Characterization of CD4-IgG 2 , a Novel Heterotetramer That Neutralizes Primary HIV Type 1 Isolates
Year: 1995
Type: article
Institution: Progenics Pharmaceuticals (United States)
Language: English
Topic: HIV Research and Treatment
Subfield: Virology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
Funder: Progenics Pharmaceuticals
OpenAlex ID: W2170412417
